Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,796 total articles
Madrigal Pharmaceuticals announced its participation in the 2026 Cantor Global Healthcare Conference where it will present its progress and pipeline advancements. The company specializes in treatments for metabolic dysfunction-associated steatohepatitis (MASH), highlighting its drug Rezdiffra, the first FDA and European Commission approved medicati…
Diginex Limited announced the departure of CEO Lubomila Jordanova and appointed interim CEO Archana Kotecha amid efforts to integrate recent acquisitions. The company also filed a listing application with Nasdaq seeking approval for a change of control related to the planned acquisition of Resulticks Global Companies Pte. Limited.
DDC Enterprise Limited announced a 29% year-over-year revenue increase to $20.2 million and positive non-GAAP Adjusted EBITDA of $1.2 million for the first half of 2026. The company improved working capital from negative $12.2 million to positive $39.4 million, grew total shareholders' equity substantially, and increased Bitcoin holdings by 145%. D…
Teamshares Inc., a NASDAQ-listed tech-enabled acquirer of small and medium-sized enterprises (SMEs), announced that its CEO Michael Brown and CFO Brian Gaebe will present at the Northcoast Research Virtual Small Cap Management Forum and the Sidoti Virtual Small Cap Conference in September 2026. Presentations and investor meetings will provide insig…
GrowGeneration Corp., a leading US supplier of specialty products for controlled environment agriculture and commercial cultivation, announced that CEO Darren Lampert will present virtually at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. The presentation will be available on demand starting September 11, and the company wi…
Geron Corporation, a hematology-focused biopharmaceutical company, announced the participation of its management team in upcoming 2026 healthcare investment conferences. The company will discuss their drug RYTELO® (imetelstat), currently approved for lower-risk myelodysplastic syndromes, and ongoing pivotal Phase 3 trials in myelofibrosis and other…
NewAmsterdam Pharma, a biopharmaceutical company specializing in oral non-statin drugs for cardiovascular risk patients with elevated LDL cholesterol, will present at two major healthcare investor conferences in September 2026. The company aims to highlight progress on its late-stage clinical candidate obicetrapib, a CETP inhibitor, which is being …
Nasdaq has completed its acquisition of Dasseti, an AI-powered platform specializing in due diligence and monitoring for investment consultants and institutional investors. Integrating Dasseti's technology into Nasdaq eVestment will extend the platform's coverage and improve efficiency in manager research, due diligence, and monitoring, especially …
InterDigital, Inc., a US-based technology development company, announced that it won a third injunction against Disney by the Unified Patent Court in Europe regarding infringements on their video technology patents. The latest injunction covers Germany and the Netherlands, with previous injunctions also secured in multiple jurisdictions globally. T…
Ascentage Pharma, a global biopharmaceutical company listed on NASDAQ and HKEX, announced its management's participation in four upcoming investor conferences in New York in September 2026. The company highlighted its novel cancer therapies pipeline, including approved products Olverembatinib and Lisaftoclax, and ongoing global registrational Phase…
Annexon, Inc. announced that its CEO, Douglas Love, will participate in several investor conferences in September 2026, including events hosted by Wells Fargo, Cantor Global Healthcare, and H.C. Wainwright. The company focuses on developing targeted immunotherapies for neuroinflammatory diseases by inhibiting the classical complement pathway. Live …
Linkhome Holdings Inc. announced the formation of its wholly owned subsidiary, Linkhome Technologies Inc., focused on AI computing infrastructure and related services. The company has begun preliminary evaluation of a potential AI computing infrastructure project in Europe that could utilize up to 144 NVIDIA GB300 GPUs to support cloud, enterprise …
Eos Energy Enterprises, MN8 Energy, and Google have announced a collaborative project to deploy an 86 MW solar power plant integrated with 100 MWh zinc-based long-duration energy storage and 280 MWh lithium-ion storage in West Virginia. The project aims to provide clean, dispatchable power to the PJM grid to support Google's data centers and region…
Acrivon Therapeutics, a clinical-stage biotech company using its proprietary Generative Phosphoproteomics AP3 platform, announced that its CEO will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference. The company is advancing innovative drug candidates including ACR-368 and ACR-2316, both showing promising clinical activi…
ALX Oncology Holdings Inc., a clinical-stage biotech company focused on cancer therapies, announced its leadership will present at three major investor conferences in September 2026. These events will include fireside chats and one-on-one meetings, during which the company will discuss its pipeline, including its lead candidate evorpacept and secon…
Pasqal (Nasdaq: PSQL), a leader in neutral-atom quantum computing, and Saudi-based True Nexus have successfully used quantum technology to encode protein structures relevant to protein gelation. This collaboration represents a pivotal step toward understanding and designing protein functionality, a key challenge in the global food and biotech indus…
Alpha Tau Medical Ltd., a NASDAQ-listed Israeli oncology therapeutics company, announced that CFO Raphi Levy will participate in the Citi 2026 Biopharma Back to School Conference and H.C. Wainwright 28th Annual Global Investor Conference in September 2026 to engage with investors and discuss their innovative Alpha DaRT therapy for solid tumors.
Aemetis, Inc., a California-based renewable fuels company, praised the unanimous passage of California Senate Bill 795 which allows fuel retailers to dispense E15 ethanol fuel using existing vapor recovery equipment. The legislation resolves implementation delays and is expected to increase ethanol demand significantly, benefiting Aemetis' ethanol …
High Roller Technologies, Inc. announced the timing for the launch of its ROLR prediction markets platform, starting with an invitation-only beta on September 15, 2026, and targeting a full public commercial launch by October 2026. The beta phase aims to validate and optimize platform performance before broad market release, marking a significant m…
3 E Network Technology Group Limited announced a $1 million private placement of 701,272 Class A shares at approximately $1.426 each to a Singapore-based entity controlled by its CEO, Dr. Tingjun Yang. The funds will support general corporate purposes and working capital to accelerate growth and innovation. The transaction was approved by independe…
Polyrizon Ltd., a Nasdaq-listed biotech company, has completed contracting with all five U.S. clinical sites for its first-in-human trial of NASARIX™, an innovative intranasal hydrogel-based allergy blocker for seasonal allergic rhinitis. This progress marks the study's move into patient pre-screening and enrollment, targeting up to 120 participant…
Purple Biotech Ltd. announced the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent covering tri-specific antibody constructs under its CAPTN-3 platform. This patent strengthens the company's intellectual property protection for its modular multispecific antibody technology designed to accelerate development of cancer i…
Palvella Therapeutics, a clinical-stage biotech company targeting rare skin diseases and vascular malformations, announced CEO Wes Kaupinen’s participation in two healthcare investor conferences in September 2026. The company highlighted its lead candidates, QTORIN™ 3.9% rapamycin anhydrous gel and QTORIN™ pitavastatin, which are investigational th…
Kyntra Bio, a biopharmaceutical company focused on oncology and rare diseases, announced management will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover company developments, including updates on their anemia treatment Roxadustat and Phase 2 ADC therapy FG-3246 for prostate cancer.
Telesat Corporation and Farcast have completed a successful demonstration of Farcast's electronically steered antenna technology using Telesat's LEO 3 test satellite. This milestone validates Farcast's architecture, which reduces size, weight, power, and cost while maintaining performance, and sets the stage for integrating this technology into a f…
